Evidence map›Paper›PMID 27720486›Full record

ArticleNeuron2016

A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons.

D Gowanlock R Tervo, Bum-Yeol Hwang, Sarada Viswanathan, Thomas Gaj, Maria Lavzin, Kimberly D Ritola, Sarah Lindo, Susan Michael, Elena Kuleshova, David Ojala and 8 more

Abstract read
In one paragraph

Article in Neuron, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 779 papers.

0numbers the graph read from it
0cells of the map it votes in
779citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

779 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

719 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

D Gowanlock R TervoJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Bum-Yeol HwangDepartment of Chemical Engineering and Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Sarada ViswanathanJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Thomas GajDepartment of Chemical Engineering and Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Maria LavzinJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA; Department of Physiology, Technion Medical School, Bat-Galim, Haifa 3525433, Israel.
Kimberly D RitolaJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Sarah LindoJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Susan MichaelJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Elena KuleshovaJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA; Institute of Higher Nervous Activity and Neurophysiology of the Russian Academy of Sciences, Moscow 117485, Russia.
David OjalaDepartment of Chemical Engineering and Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA.
Cheng-Chiu HuangJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Charles R GerfenJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA; Laboratory of Systems Neuroscience, National Institute of Mental Health, Bethesda, MD 20892, USA.
Jackie SchillerJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA; Department of Physiology, Technion Medical School, Bat-Galim, Haifa 3525433, Israel.
Joshua T DudmanJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Adam W HantmanJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
Loren L LoogerJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA.
David V SchafferDepartment of Chemical Engineering and Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA. Electronic address: schaffer@berkeley.edu.
Alla Y KarpovaJanelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA 20147, USA. Electronic address: alla@janelia.hhmi.org.

Funding

Functional Organization Of The Cerebral Cortex and Basal GangliaZIAMH002497 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI GERFEN, CHARLES R · 2009 to 2025
$18.3M
Directed Evolution of Adeno-Associated Virus for Retinal Gene TherapyR01EY022975 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI FLANNERY, JOHN GERARD, SCHAFFER, DAVID V · 2014 to 2018
$2.1M
Engineering Molecular Sensors for Stem Cell FunctionR21NS048248 · NINDS · UNIVERSITY OF CALIFORNIA BERKELEY · PI SCHAFFER, DAVID V · 2004 to 2005
$329k
Therapeutic genome editing for amyotrophic lateral sclerosisF32GM113446 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI GAJ, THOMAS · 2015 to 2017
$125k
NEI NIH HHS R01 EY022975NIGMS NIH HHS F32 GM113446NINDS NIH HHS R21 NS048248
6 · The paper itself

Abstract

Efficient retrograde access to projection neurons for the delivery of sensors and effectors constitutes an important and enabling capability for neural circuit dissection. Such an approach would also be useful for gene therapy, including the treatment of neurodegenerative disorders characterized by pathological spread through functionally connected and highly distributed networks. Viral vectors, in particular, are powerful gene delivery vehicles for the nervous system, but all available tools suffer from inefficient retrograde transport or limited clinical potential. To address this need, we applied in vivo directed evolution to engineer potent retrograde functionality into the capsid of adeno-associated virus (AAV), a vector that has shown promise in neuroscience research and the clinic. A newly evolved variant, rAAV2-retro, permits robust retrograde access to projection neurons with efficiency comparable to classical synthetic retrograde tracers and enables sufficient sensor/effector expression for functional circuit interrogation and in vivo genome editing in targeted neuronal populations. VIDEO ABSTRACT.

Indexed as

DependovirusGenetic VectorsGene Transfer TechniquesAnimalsCapsidCerebellumFemaleGene EditingMaleMiceNeuronsRats

Identifiers

PMID27720486
PMCPMC5872824

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.